UK Crackdown On Illegal Sales Of Viagra
A special enquiry unit has been set up by the UK Medicines ControlAgency's enforcement division to stop the illegal sale of Pfizer's new erectile dysfunction drug Viagra (sildenafil).
An MCA statement noted that Viagra is an unlicensed medicine in the UK and can only be sold or supplied to an individual patient via a prescription by a doctor; this is possible where a clinical need has been identified.
Any other form of retail sale or supply of Viagra, including advertising, is a criminal offence under the Medicines Act 1968, and this can carry a maximum penalty of two years imprisonment and an unlimited fine. The MCA says it is currently investigating illegal trading and advertising activities and will take action against traders.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze